 |
|
Early-Onset and Late-Onset Neonatal Group B Streptococcal Disease—United States, 1996-2004
JAMA. 2006;295:1371-1372.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MMWR. 2005;54:1205-1208
2 figures, 1 table omitted
In 2002, CDC, the American College of Obstetricians and Gynecologists (ACOG), and the American Academy of Pediatrics (AAP) issued revised guidelines for prevention of perinatal invasive group B streptococcal (GBS) disease.1-2 These guidelines recommend universal screening of pregnant women for rectovaginal GBS colonization at 35-37 weeks' gestation and administering intrapartum antimicrobial prophylaxis to carriers. To assess the impact of the guidelines on multistate trends in neonatal GBS disease incidence, CDC analyzed data from the Active Bacterial Core surveillance (ABCs) system from 1996-2004. This report summarizes the results of that analysis, which determined that incidence of GBS disease in infants aged 0-6 days (i.e., early-onset disease) in 2004 had decreased by 31% from 2000-2001, the period immediately before universal screening was implemented. Incidence of GBS disease in infants aged 7-89 days (i.e., late-onset disease) remained unchanged during the 9-year period reviewed. Continued monitoring is . . . [Full Text of this Article] Reported by:
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Bioinformatic insights into the biosynthesis of the Group B carbohydrate in Streptococcus agalactiae
Sutcliffe et al.
Microbiology 2008;154:1354-1363.
ABSTRACT
| FULL TEXT
|
